BIOMARKER:

ALK translocation

Entrez ID:

Related biomarkers:

‹

›

ALK translocation ALK translocation	Soft Tissue Sarcoma Soft Tissue Sarcoma	ALK translocation ALK translocation	Soft Tissue Sarcoma Soft Tissue Sarcoma	crizotinib Sensitive: A2 - Guideline	crizotinib Sensitive: A2 - Guideline
ALK translocation ALK translocation	Soft Tissue Sarcoma Soft Tissue Sarcoma	ALK translocation ALK translocation	Soft Tissue Sarcoma Soft Tissue Sarcoma	brigatinib Sensitive: A2 - Guideline	brigatinib Sensitive: A2 - Guideline
ALK translocation ALK translocation	Soft Tissue Sarcoma Soft Tissue Sarcoma	ALK translocation ALK translocation	Soft Tissue Sarcoma Soft Tissue Sarcoma	ceritinib Sensitive: A2 - Guideline	ceritinib Sensitive: A2 - Guideline
ALK translocation ALK translocation	Soft Tissue Sarcoma Soft Tissue Sarcoma	ALK translocation ALK translocation	Soft Tissue Sarcoma Soft Tissue Sarcoma	lorlatinib Sensitive: A2 - Guideline	lorlatinib Sensitive: A2 - Guideline
ALK translocation ALK translocation	Non Small Cell Lung Cancer NSCLC	ALK translocation ALK translocation	Non Small Cell Lung Cancer NSCLC	tislelizumab Sensitive: C2 – Inclusion Criteria	tislelizumab Sensitive: C2 – Inclusion Criteria
ALK translocation ALK translocation	Non Small Cell Lung Cancer NSCLC	ALK translocation ALK translocation	Non Small Cell Lung Cancer NSCLC	durvalumab Sensitive: C2 – Inclusion Criteria	durvalumab Sensitive: C2 – Inclusion Criteria
ALK translocation ALK translocation	Non Small Cell Lung Cancer NSCLC	ALK translocation ALK translocation	Non Small Cell Lung Cancer NSCLC	ALK inhibitor Sensitive: C4 – Case Studies	ALK inhibitor Sensitive: C4 – Case Studies